Clinical Efficacy of Angulated Screw-retained and Cemented Single Implant Crowns in Esthetic Region
Comparison of the Short-term Clinical Efficacy of Angulated Screw-retained and Cemented Single Implant Crowns in Esthetic Region: A Randomized Controlled Clinical Trial
1 other identifier
interventional
60
1 country
1
Brief Summary
Objective: To compare the clinical efficacy of angulated screw-retained and cemented single implant crowns(SIC) in esthetic region. Methods/Design: The study was a prospective, single center, randomized controlled clinical trial. Patients with the needs of single tooth restoration in esthetics region were recruited from Oct. 2018 to Aug. 2019. Sixty patients were enrolled in the present study and they were randomly assigned into two groups: angulated screw-retained group(AG, 30 patients) and cemented group (CG,30 patients). Clinical and radiological evaluations were performed on the day of final crowns delivery and 12 months later. Implant survival rate, marginal bone loss(MBL), pro-inflammatory cytokinesin peri-implant crevicular fluid (PICF)(TNF-α, IL-6), mechanical complications, peri-implant conditions(mPI, PD, BOP%), pink esthetics score/white esthetics score (PES/ WES) and patients satisfaction were assessed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 1, 2020
CompletedFirst Posted
Study publicly available on registry
September 7, 2020
CompletedSeptember 7, 2020
September 1, 2020
1 year
September 1, 2020
September 4, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Marginal bone loss
Peri-apical radiographs with paralleling technique wereperformed on the day offinal restorations delivery and 1-year visit. Implant length was used as calibration reference. The distance between restoration margin and the most coronal level of implant-bone contactwas recorded. Final result was calculated as themean value of the mesial and distal sites
1year
Secondary Outcomes (8)
Survival rate.
1 year
Pro-inflammatory cytokinesin peri-implant crevicular fluid (PICF)
1 year
Mechanical complications
1 year
pocket probing depth(PD)
1 year
PES/WES
1 year
- +3 more secondary outcomes
Study Arms (2)
angulated screw-retained group(AG)
EXPERIMENTALcemented group (CG)
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- \) age≥18;
- \) Single dental implant in the esthetic region;
- \) adjacent to natural teeth;
- \) absence of oral mucosal disease and oral infection;
- )implants withconical connection (Nobel Active, Nobel Biocare® or NobelReplace Conical Connection, Nobel Biocare®);
- )patients with the willingness of all-ceramic permanent restorations.
You may not qualify if:
- )Multiple implants in the esthetic region, or the restoration is a bridge;
- )Heavy smokers (\>10 cigarettes/day);
- \) the angle between implant axis and restoration axis\>25°;
- \) uncontrolled periodontitis;
- \) with systematic diseases that may affect implant therapy, such as uncontrolled diabetes mellitus (Fasting blood-glucose\>7.2mmol/L, Glycosylated hemoglobin \>7%), current intake of bisphosphonates (treatment for malignancy), pregnant(or plan to get pregnant), with history of radiation therapy in head and neck region;
- \) Unwilling to participate in the present study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Junyu Shilead
Study Sites (1)
Jun-Yu Shi
Shanghai, Shanghai Municipality, 200011, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 1, 2020
First Posted
September 7, 2020
Study Start
August 1, 2018
Primary Completion
August 1, 2019
Study Completion
August 1, 2020
Last Updated
September 7, 2020
Record last verified: 2020-09